Tumor Mutation Burden Correlates With Efficacy of Chemotherapy/Targeted Therapy in Advanced Non–Small Cell Lung Cancer

Objectives: Accumulating evidence has illustrated greater benefit of immunotherapy in tumors with high tumor mutation burden (TMB), whereas its impact on targeted therapy or chemotherapy is undefined. Herein, we evaluated TMB outside of immuno-oncology in epidermal growth factor receptor (EGFR)–muta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chen, Shi, Xun, Zhao, Jun, He, Qiong, Fan, Yun, Xu, Weizhen, Shao, Yang, Yu, Xinmin, Jin, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201001/
https://www.ncbi.nlm.nih.gov/pubmed/32411590
http://dx.doi.org/10.3389/fonc.2020.00480

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201001/
https://www.ncbi.nlm.nih.gov/pubmed/32411590
http://dx.doi.org/10.3389/fonc.2020.00480

Ejemplares similares